Applications of 2-Amino-5-Iodopyridine in Industrial Manufacturing

2-Amino-5-Iodopyridine serves as a critical intermediate in multiple advanced manufacturing sectors. As a direct manufacturer, we supply this specialty compound for high-value chemical synthesis, focusing on downstream processes that leverage its unique substitution pattern for efficient molecular construction. Below, we detail specific application scenarios, highlighting processing steps, regulatory frameworks, industry usage ratios, and related end products to support optimized industrial integration.

1. Pharmaceutical Intermediate for Anticancer Agents

In pharmaceutical API synthesis, 2-Amino-5-Iodopyridine is essential for constructing pyridine-based frameworks in kinase inhibitors and other novel anticancer drug candidates. Major producers employ it in Suzuki or Buchwald–Hartwig coupling steps to introduce complex aryl groups, utilizing its position-selective iodination to enhance target molecule diversity. Formulation chemists adjust its inclusion rate based on reaction yield and impurity profiles, aiming for regulatory compliance in all downstream purification stages. Synthetic chemists value its efficient reactivity in multi-step routes, helping bring new oncology treatments to market faster.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia (Ph. Eur.) synthesis guidelines
• US FDA 21 CFR Part 210/211 for finished pharmaceuticals
• Chinese Pharmacopoeia for registered drug substances

Typical usage ratio

• 0.5–2.0 molar equivalents as a limiting or key reagent, with precise ratios based on targeted drug substance batch scale and transformation efficiency

Downstream process integration

• Charged as a key reactant in palladium-catalyzed coupling reactions (Suzuki, Buchwald–Hartwig)
• Employed in multi-step syntheses, immediately following condensation or amination of precursor fragments
• Purified in intermediate stages using chromatographic or crystallization purification

Final product types

• API intermediates for new generation kinase inhibitors
• Small-molecule cancer therapeutics, including clinical research compounds
• Reference standards for impurity profiling

2. Agrochemical Construction Block in Fungicide Synthesis

In agrochemical production, formulators use this compound to assemble complex pesticide and fungicide scaffolds that require precise halogen substitution. Large-volume agrochemical plants value its halogenation and amino functionality for efficient build-up of heterocyclic systems, especially in triazole and pyridine-based crop protection agents. It enters production workflows at the coupling stage, where its loading depends on the synthetic target and minimum effective concentration set by regulatory residue limits. This enables strict control over product purity and environmentally compliant formulation.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• OECD Guidelines for Testing of Chemicals (Pesticide Active Substances)
• REACH (EC 1907/2006) registration and reporting for agrochemical intermediates

Typical usage ratio

• 0.2–1.0 molar equivalents per step, adjusted to batch size and conversion yield requirements (<0.5% w/w in final product formulation)

Downstream process integration

• Introduced at N-arylation or C–C coupling steps for fungicide backbone assembly
• Incorporated before formulation of technical concentrate
• Removed as unreacted intermediate in final crystallization and quality screening

Final product types

• Pyridine- and triazole-derived fungicides (e.g., for cereal and fruit crops)
• Broad-spectrum pesticide intermediates
• Technical concentrates for formulation into suspension concentrates or emulsifiable concentrates

3. Building Block for API Reference Standard Synthesis

Contract research and pharmaceutical QC labs depend on high-purity 2-Amino-5-Iodopyridine to synthesize customized impurity reference standards and analytical controls. This usage requires absolute traceability and documentation for regulatory filings and lot release testing. Standard-makers weigh input ratios strictly against targeted reference compound output, focusing on minimizing carryover and meeting analytical reproducibility. The material typically enters at the targeted iodopyridine coupling stage, ensuring structural integrity of resulting markers and calibration controls for method validation.

Industry compliance standards

• USP General Chapter <621> Chromatography requirements
• ISO/IEC 17025 quality management for analytical reference material producers
• ICH Q3A/B guidelines for impurity reference standards in pharmaceuticals

Typical usage ratio

• 1.0–1.5 molar equivalents, optimized for yield and purity in each analytical reference batch, typically <10 g per synthetic run

Downstream process integration

• Used in late-stage small-molecule synthesis for reference standard formation
• Submitted to HPLC and MS purity verification before release
• Integrated into certified reference material packaging workflow for global shipment

Final product types

• Synthesized reference standards for regulated pharmaceutical APIs
• Analytical performance controls for process validation and method transfer
• Certified impurity markers for regulatory filing support

4. Advanced Material Precursor for OLED Display Chemicals

Electronics chemical manufacturers utilize 2-Amino-5-Iodopyridine as a key intermediate when assembling cores for organic light-emitting diode (OLED) emitters and charge transport materials. Its electron-rich pyridine ring and specific iodination enable high-performance small-molecule and polymeric OLED materials. Engineers adjust its batch input ratio in line with electronic function and layer application, targeting both emission efficiency and stability. The intermediate joins at the core amination or halide exchange step, which determines downstream semiconductor performance and product consistency.

Industry compliance standards

• IEC 62341 (OLED panel safety and performance standards)
• RoHS Directive 2011/65/EU for chemical substances in electronics
• ISO 9001 for electronic materials manufacturing

Typical usage ratio

• 0.1–0.6 w/w equivalents relative to core monomers, adjusted by specific light emission or transport target, typically at 95–99% assay

Downstream process integration

• Incorporated during the construction of hole or electron transport molecules
• Engaged in halide exchange processes for custom device tuning
• Purified and transferred into ink or solution formulations for OLED layer deposition

Final product types

• Small-molecule OLED emitters for high-resolution display panels
• Functionalized transport layers for OLED device stacks
• Semiconductor-grade intermediate compounds for solid-state lighting